document.write("
"); document.write("
Blandino,\ A.*\ ; Scherer,\ D.*\ ; Boekstegers,\ F.*\ ; Rounge,\ T.B.*\ ; Langseth,\ H.*\ ; Roessler,\ S.*\ ; Hveem,\ K.*\ ; Brenner,\ H.*\ ; Pechlivanis,\ S.\ ; Waldenberger,\ M.\ ; Lorenzo Bermejo,\ J.*
"); document.write("
Small-RNA sequencing reveals potential serum biomarkers for gallbladder cancer: Results from a three-stage collaborative study of large European prospective cohorts.
"); document.write("
Eur. J. Cancer 214:115138 (2025)
"); document.write("
"); document.write("
"); document.write("
Holch,\ J.W.*\ ; Ohnmacht,\ A.\ ; Stintzing,\ S.*\ ; Heinrich,\ K.*\ ; Weiss,\ L.*\ ; Probst,\ V.*\ ; Stahler,\ A.*\ ; Fischer von Weikersthal,\ L.*\ ; Decker,\ T.*\ ; Kiani,\ A.*\ ; Kaiser,\ F.*\ ; Heintges,\ T.*\ ; Kahl,\ C.*\ ; Kullmann,\ F.*\ ; Link,\ H.*\ ; Höffkes,\ H.G.*\ ; Moehler,\ M.*\ ; Modest,\ D.P.*\ ; Menden,\ M.P.\ ; Heinemann,\ V.*
"); document.write("
FOLFIRI with cetuximab or bevacizumab in RAS wild-type metastatic colorectal cancer: Refining first-line treatment selection by combining clinical parameters: A post hoc analysis of the randomized open-label phase III trial FIRE-3/AIO KRK0306.
"); document.write("
Eur. J. Cancer 220:115388 (2025)
"); document.write("
"); document.write("
"); document.write("
Lombardo,\ E.*\ ; Hess J.\ ; Kurz,\ C.*\ ; Riboldi,\ M.*\ ; Marschner,\ S.*\ ; Baumeister,\ P.\ ; Lauber,\ K.\ ; Pflugradt,\ U.\ ; Walch,\ A.K.\ ; Canis,\ M.\ ; Klauschen,\ F.*\ ; Zitzelsberger,\ H.\ ; Belka,\ C.\ ; Landry,\ G.*\ ; Unger,\ K.
"); document.write("
DeepClassPathway: Molecular pathway aware classification using explainable deep learning.
"); document.write("
Eur. J. Cancer 176, 41-49 (2022)
"); document.write("
"); document.write("
"); document.write("
Issels,\ R.D.*\ ; Nößner,\ E.\ ; Lindner,\ L.H.*\ ; Schmidt,\ M.*\ ; Albertsmeier,\ M.*\ ; Blay,\ J.Y.*\ ; Stutz,\ E.*\ ; Xu,\ Y.*\ ; Buecklein,\ V.*\ ; Altendorf-Hofmann,\ A.*\ ; Abdel-Rahman,\ S.*\ ; Mansmann,\ U.*\ ; von Bergwelt-Baildon,\ M.*\ ; Knoesel,\ T.*
"); document.write("
Immune infiltrates in patients with localised high-risk soft tissue sarcoma treated with neoadjuvant chemotherapy without or with regional hyperthermia: A translational research program of the EORTC 62961-ESHO 95 randomised clinical trial.
"); document.write("
Eur. J. Cancer 158, 123-132 (2021)
"); document.write("
"); document.write("
"); document.write("
Benmebarek,\ M.*\ ; Karches,\ C.H.*\ ; Schmidbauer,\ M.L.*\ ; Kurzay,\ M.*\ ; Klaus,\ R.*\ ; Geiger,\ M.*\ ; Rataj,\ F.*\ ; Cadilha,\ B.*\ ; Lesch,\ S.*\ ; Heise,\ C.*\ ; Murr,\ R.*\ ; vom Berg,\ J.*\ ; Jastroch,\ M.\ ; Lamp,\ D.\ ; Niederfellner,\ G.*\ ; Sustmann,\ C.*\ ; Endres,\ S.*\ ; Klein,\ C.*\ ; Kobold,\ S.*
"); document.write("
Characterization of bispecific antibodies that drive synthetic agonistic receptor - transduced T cells to mediate specific and conditional therapy in human pancreatic cancer models.
"); document.write("
Eur. J. Cancer 110, S3-S3 (2019)
"); document.write("
"); document.write("
"); document.write("
Freudenreich,\ M.*\ ; Tischer,\ J.*\ ; Kroell,\ T.*\ ; Kremser,\ A.*\ ; Dreyssig,\ J.*\ ; Grabrucker,\ C.*\ ; Liepert,\ A.*\ ; Kolb,\ H.*\ ; Schmid,\ C.*\ ; Schmetzer,\ H.
"); document.write("
Clinical relevance of in vitro generated dendritic cells of leukemic origin to predict response to immunotherapy in patients with AML and MDS.
"); document.write("
Eur. J. Cancer 110, S29-S29 (2019)
"); document.write("
"); document.write("
"); document.write("
Merle,\ M.*\ ; Fischbacher,\ D.*\ ; Liepert,\ A.*\ ; Grabrucker,\ C.*\ ; Kroell,\ T.*\ ; Kremser,\ A.*\ ; Dreyssig,\ J.*\ ; Freudenreich,\ M.*\ ; Schuster,\ F.*\ ; Borkhardt,\ A.*\ ; Kraemer,\ D.*\ ; Koehne,\ C.*\ ; Kolb,\ H.J.\ ; Schmid,\ C.*\ ; Schmetzer,\ H.
"); document.write("
Conversion of AML-blasts to leukemia-derived dendritic cells (DCleu) in \'DC-culture-media\' shifts the (serum) chemokine-release profile to a more \'inflammatory\' (in culture) going along with improved antileukemic T-cell-reactivity.
"); document.write("
Eur. J. Cancer 110, S24-S24 (2019)
"); document.write("
"); document.write("
"); document.write("
Fröhlich,\ F.\ ; Shadrin,\ A.*\ ; Kessler,\ T.*\ ; Wierling,\ C.*\ ; Heinig,\ M.\ ; Theis,\ F.J.\ ; Lange,\ B.M.*\ ; Lehrach,\ H.*\ ; Hasenauer,\ J.
"); document.write("
Large-scale modeling of cancer signaling: Mechanistic modeling meets Big Data.
"); document.write("
Eur. J. Cancer 68, S44-S44 (2016)
"); document.write("
"); document.write("
"); document.write("
Hensel,\ T.*\ ; Giorgi,\ C.*\ ; Becker-Dettling,\ F.*\ ; Calzada-Wack,\ J.\ ; Neff,\ F.\ ; Schmidt,\ O.*\ ; Schäfer,\ B.W.*\ ; Burdach,\ S.*\ ; Richter,\ G.H.*
"); document.write("
Inhibition of BET bromodomain proteins and the PI3K pathway in Ewing sarcoma down regulates the specific transcriptional program, inhibits tumorigenicity and increases apoptosis in Ewing sarcoma.
"); document.write("
Eur. J. Cancer 68, S48-S48 (2016)
"); document.write("
"); document.write("
"); document.write("
Luber,\ B.*\ ; Keller,\ S.*\ ; Zwingenberger,\ G.*\ ; Ebert,\ K.*\ ; Maier,\ D.*\ ; Geier,\ B.*\ ; Theis,\ F.J.\ ; Hasenauer,\ J.\ ; Huge,\ S.\ ; Meyer-Hermann,\ M.\ ; Dehghany,\ J.\ ; Walch,\ A.K.\ ; Aichler,\ M.\ ; Lordick,\ F.*\ ; Haffner,\ I.*
"); document.write("
Identification of predictive response and resistance factors to targeted therapy in gastric cancer using a systems medicine approach.
"); document.write("
Eur. J. Cancer 68, S135-S135 (2016)
"); document.write("
"); document.write("
"); document.write("
Tinhofer,\ I.*\ ; Budach,\ V.*\ ; Saki,\ M.*\ ; Konschak,\ R.*\ ; Niehr,\ F.*\ ; Jöhrens,\ K.*\ ; Weichert,\ W.*\ ; Linge,\ A.*\ ; Lohaus,\ F.*\ ; Krause,\ M.*\ ; Neumann,\ K.*\ ; Endris,\ V.*\ ; Sak,\ A.*\ ; Stuschke,\ M.*\ ; Balermpas,\ P.*\ ; Rödel,\ C.*\ ; Avlar,\ M.*\ ; Grosu,\ A.-L.*\ ; Abdollahi,\ A.*\ ; Debus,\ J.*\ ; Belka,\ C.*\ ; Pigorsch,\ S.*\ ; Combs,\ S.E.\ ; Mönnich,\ D.*\ ; Zips,\ D.*\ ; Baumann,\ M.*
"); document.write("
Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation.
"); document.write("
Eur. J. Cancer 57, 78-86 (2016)
"); document.write("
"); document.write("
"); document.write("
Vergalli,\ J.\ ; Carletl,\ M.\ ; Hoffmann,\ T.*\ ; Rothe,\ M.*\ ; Zuber,\ J.*\ ; Jeremias,\ I.
"); document.write("
X-Linked inhibitor of apoptosis protein (XIAP) exhibits an essential role of patients\' acute lymphoblastic leukemia cells growing in vivo.
"); document.write("
Eur. J. Cancer 68, S58-S59 (2016)
"); document.write("
"); document.write("
"); document.write("
von Heyking,\ K.*\ ; Roth,\ L.C.*\ ; Ertl,\ M.*\ ; Schmidt,\ O.*\ ; Calzada-Wack,\ J.\ ; Neff,\ F.\ ; Lawlor,\ E.R.*\ ; Burdach,\ S.*\ ; Richter,\ G.*
"); document.write("
The posterior HOXD locus: Its contribution to phenotype and malignancy of Ewing sarcoma.
"); document.write("
Eur. J. Cancer 68, S47-S47 (2016)
"); document.write("
"); document.write("
"); document.write("
Gimenez-Aznar,\ I.\ ; Michna,\ A.\ ; Ludwig,\ H.*\ ; Braselmann,\ H.\ ; Klein,\ D.*\ ; Ohrt,\ M.*\ ; Schoetz,\ U.*\ ; Kuger,\ S.\ ; Schneider,\ L.*\ ; Schuettrumpf,\ L.\ ; Jendrossek,\ V.*\ ; Belka,\ C.\ ; Zangen,\ V.\ ; Unger,\ K.\ ; Zitzelsberger,\ H.\ ; Lauber,\ K.\ ; Hess J.
"); document.write("
Fanconi anemia, complementation group A (FancA) overexpression confers radioresistance to oral keratinocytes.
"); document.write("
Eur. J. Cancer 51, S121 (2015)
"); document.write("
"); document.write("
"); document.write("
Neff,\ F.*\ ; Kirsch,\ D.G.*\ ; Saur,\ D.*\ ; Schmid,\ R.M.*\ ; Heikenwälder,\ M.\ ; Siveke,\ J.T.*
"); document.write("
Notch triggers myeloid reprogramming in murine pancreatic cancer.
"); document.write("
Eur. J. Cancer 51, S2 (2015)
"); document.write("
"); document.write("
"); document.write("
Schnorfeil,\ F.M.\ ; Lichtenegger,\ F.S.\ ; Geiger,\ C.*\ ; Henschler,\ R.*\ ; Wagner,\ B.*\ ; Bigalke,\ I.*\ ; Kvalheim,\ G.*\ ; Schendel,\ D.J.*\ ; Hiddemann,\ W.*\ ; Subklewe,\ M.
"); document.write("
Vaccination with next-generation dendritic cells for aml postremission therapy induces antigen-specific T cell responses.
"); document.write("
Eur. J. Cancer 51, S8 (2015)
"); document.write("
"); document.write("
"); document.write("
Bauer,\ J.\ ; Sandhöfer,\ N.\ ; Hiddemann,\ W.\ ; Spiekermann,\ K.
"); document.write("
Novel FLT3 mutation shows dominant negative effects on the wild-type FLT3 receptor.
"); document.write("
Eur. J. Cancer 50, S121 (2014)
"); document.write("
"); document.write("
"); document.write("
Burton,\ N.*\ ; Ulrich,\ A.*\ ; Driessen,\ W.H.P.*\ ; Morscher,\ S.*\ ; Sardella,\ T.*\ ; Nasanova,\ E.*\ ; Razansky,\ D.\ ; Ntziachristos,\ V.
"); document.write("
Real time noninvasive 2D and 3D Multispectral Optoacoustic Tomography (MSOT) for clinical imaging of vessel oxygenation and melanin distribution.
"); document.write("
Eur. J. Cancer 50, S157 (2014)
"); document.write("
"); document.write("
"); document.write("
Driessen,\ W.H.P.*\ ; Morscher,\ S.*\ ; Burton,\ N.C.*\ ; Sardella,\ T.*\ ; Razansky,\ D.\ ; Ntziachristos,\ V.
"); document.write("
Novel approaches for dynamic biomarker imaging by Multispectral Optoacoustic Tomography (MSOT).
"); document.write("
Eur. J. Cancer 50, S55 (2014)
"); document.write("
"); document.write("
"); document.write("
Gimenez-Aznar,\ I.\ ; Michna,\ A.\ ; Hieber,\ L.\ ; Braselmann,\ H.\ ; Jendrossek,\ V.*\ ; Zangen,\ V.\ ; Unger,\ K.\ ; Zitzelsberger,\ H.\ ; Lauber,\ K.*\ ; Hess J.
"); document.write("
FancA overexpression confers radioresistance to cells of head and neck squamous cell carcinoma.
"); document.write("
Eur. J. Cancer 50, S229 (2014)
"); document.write("
"); document.write("
"); document.write("
Höfig,\ I.\ ; Falkenberg,\ N.\ ; Rosemann,\ M.\ ; Szumielewski,\ J.\ ; Richter,\ S.\ ; Atkinson,\ M.J.\ ; Aubele,\ M.\ ; Anastasov,\ N.
"); document.write("
Relevance of 3D-microtissues to investigate the therapeutic oncogenes HER2 and PTK6 in breast cancer.
"); document.write("
Eur. J. Cancer 50, S226 (2014)
"); document.write("
"); document.write("
"); document.write("
Huber,\ M.\ ; Falkenberg,\ N.\ ; Schmitt,\ M.*\ ; Braselmann,\ H.\ ; Mall,\ R.\ ; Jakovac,\ M.\ ; Walch,\ A.K.\ ; Höfler,\ H.\ ; Aubele,\ M.
"); document.write("
uPAR and its interaction partners: potential new therapy targets in triple negative breast cancer.
"); document.write("
Eur. J. Cancer 50, S161-S162 (2014)
"); document.write("
"); document.write("
"); document.write("
Lee,\ M.S.\ ; Gaertner,\ F.C.*\ ; Pellegata,\ N.S.
"); document.write("
Regulation of norepinephrine transporter expression in pheochromocytoma by dual PI3K/mTOR inhibition.
"); document.write("
Eur. J. Cancer 50, S154 (2014)
"); document.write("
"); document.write("
"); document.write("
Leinhäuser,\ I.\ ; Atkinson,\ M.J.\ ; Pellegata,\ N.S.
"); document.write("
The transcription factor Phox2a plays a pro-tumorigenic role in pheochromocytoma.
"); document.write("
Eur. J. Cancer 50, S160 (2014)
"); document.write("
"); document.write("
"); document.write("
Martin,\ A.\ ; Felipe-Abrio,\ I.*\ ; Obrador-Hevia,\ A.*\ ; Calabuig-Farinas,\ S.*\ ; Alemany,\ R.*\ ; Martin,\ J.*
"); document.write("
Cullin-RING ligases inhibition is a potential new therapeutic strategy in soft tissue sarcomas.
"); document.write("
Eur. J. Cancer 50, S159 (2014)
"); document.write("
"); document.write("
"); document.write("
Michna,\ A.\ ; Braselmann,\ H.\ ; Guertler,\ A.*\ ; Gomolka,\ M.*\ ; Hornhardt,\ S.*\ ; Bluethgen,\ N.*\ ; Sieber,\ A.*\ ; Zitzelsberger,\ H.\ ; Unger,\ K.
"); document.write("
Identification of molecular targets and signalling networks that influence hypersensitivity to ionizing radiation.
"); document.write("
Eur. J. Cancer 50, S134 (2014)
"); document.write("
"); document.write("
"); document.write("
Morscher,\ S.*\ ; Driessen,\ W.H.P.*\ ; Burton,\ N.C.B.*\ ; Sardella,\ T.*\ ; Razansky,\ D.\ ; Ntziachristos,\ V.
"); document.write("
Pharmacokinetic modelling in Dynamic Contrast Enhanced Multispectral Optoacoustic Tomography (DCE-MSOT).
"); document.write("
Eur. J. Cancer 50, S160-S161 (2014)
"); document.write("
"); document.write("
"); document.write("
Pastula,\ A.*\ ; Hauck,\ S.M.\ ; Janssen,\ K.P.*\ ; Schmid,\ R.M.*\ ; Quante,\ M.*
"); document.write("
Mesenchymal cells regulate growth of intestinal crypts by a Wnt independent mechanism in 3D culture system.
"); document.write("
Eur. J. Cancer 50, S63 (2014)
"); document.write("
"); document.write("
"); document.write("
Pellegata,\ N.S.\ ; Molatore,\ S.\ ; Neff,\ F.\ ; Irmler,\ M.\ ; Pulz,\ E.\ ; Roncaroli,\ F.*
"); document.write("
p27 is a haploinsufficient tumor suppressor in MENX rats and this associates with the development of invasive medullary thyroid carcinoma.
"); document.write("
Eur. J. Cancer 50, S57 (2014)
"); document.write("
"); document.write("
"); document.write("
Selmansberger,\ M.\ ; Feuchtinger,\ A.\ ; Zurnadzhy,\ L.*\ ; Höfig,\ I.\ ; Bogdanova,\ T.*\ ; Walch,\ A.K.\ ; Unger,\ K.\ ; Zitzelsberger,\ H.\ ; Hess J.
"); document.write("
CLIP2 as radiation biomarker in papillary thyroid carcinoma.
"); document.write("
Eur. J. Cancer 50, S113 (2014)
"); document.write("
"); document.write("
"); document.write("
Simonavicius,\ N.\ ; Seubert,\ B.*\ ; Borsig,\ L.*\ ; Wohlleber,\ D.*\ ; Browning,\ J.*\ ; Krueger,\ A.*\ ; Heikenwälder,\ M.
"); document.write("
Lymphotoxin signalling alters the vasculature to increase tumour cell metastasis.
"); document.write("
Eur. J. Cancer 50, S88 (2014)
"); document.write("
"); document.write("
"); document.write("
Weller,\ P.*\ ; Bankfalvi,\ A.*\ ; Gu,\ X.*\ ; Dominas,\ N.*\ ; Lehnerdt,\ G.F.*\ ; Zeidler,\ R.\ ; Lang,\ S.*\ ; Brandau,\ S.*\ ; Dumitru,\ C.A.*
"); document.write("
The role of tumour FoxP3 as prognostic marker in different subtypes of head and neck cancer.
"); document.write("
Eur. J. Cancer 50, 1291-1300 (2014)
"); document.write("
"); document.write("
"); document.write("
Wilke,\ C.\ ; Hess J.\ ; Pitea,\ A.\ ; Schmidl,\ D.\ ; Klymenko,\ S.*\ ; Zitzelsberger,\ H.\ ; Unger,\ K.
"); document.write("
Comparative global characterisation of microRNA-expression in radiation-associated and sporadic breast carcinomas.
"); document.write("
Eur. J. Cancer 50, S229 (2014)
"); document.write("
"); document.write("
"); document.write("
Cote,\ M.L.*\ ; Liu,\ M.*\ ; Bonassi,\ S.*\ ; Neri,\ M.*\ ; Schwartz,\ A.G.*\ ; Christiani,\ D.C.*\ ; Spitz,\ M.R.*\ ; Muscat,\ J.E.*\ ; Rennert,\ G.*\ ; Aben,\ K.K.*\ ; Andrew,\ A.S.*\ ; Bencko,\ V.*\ ; Bickeböller,\ H.*\ ; Boffetta,\ P.*\ ; Brennan,\ P.*\ ; Brenner,\ H.*\ ; Duell,\ E.J.*\ ; Fabianova,\ E.*\ ; Field,\ J.K.*\ ; Foretova,\ L.*\ ; Friis,\ S.*\ ; Harris,\ C.C.*\ ; Holcatova,\ I.*\ ; Hong,\ Y.C.*\ ; Isla,\ D.*\ ; Janout,\ V.*\ ; Kiemeney,\ L.A.*\ ; Kiyohara,\ C.*\ ; Lan,\ Q.*\ ; Lazarus,\ P.*\ ; Lissowska,\ J.*\ ; Le Marchand,\ L.*\ ; Mates,\ D.*\ ; Matsuo,\ K.*\ ; Mayordomo,\ J.I.*\ ; McLaughlin,\ J.R.*\ ; Morgenstern,\ H.*\ ; Mueller,\ H.*\ ; Orlow,\ I.*\ ; Park,\ B.J.*\ ; Pinchev,\ M.*\ ; Raji,\ O.Y.*\ ; Rennert,\ H.S.*\ ; Rudnai,\ P.*\ ; Seow,\ A.*\ ; Stücker,\ I.*\ ; Szeszenia-Dabrowska,\ N.*\ ; Teare,\ M.D.*\ ; Tjonnelan,\ A.*\ ; Ugolini,\ D.*\ ; van der Heijden,\ H.F.M.*\ ; Wichmann,\ H.-E.\ ; Wiencke,\ J.K.*\ ; Woll,\ P.J.*\ ; Yang,\ P.*\ ; Zaridze,\ D.*\ ; Zhang,\ Z.F.*\ ; Etzel,\ C.J.*\ ; Hung,\ R.J.*
"); document.write("
Increased risk of lung cancer in individuals with a family history of the disease: A pooled analysis from the International Lung Cancer Consortium.
"); document.write("
Eur. J. Cancer 48, 1957-1968 (2012)
"); document.write("
"); document.write("
"); document.write("
Eisenhofer,\ G.*\ ; Lenders,\ J.W.*\ ; Siegert,\ G.*\ ; Bornstein,\ S.R.*\ ; Friberg,\ P.*\ ; Milosevic,\ D.*\ ; Mannelli,\ M.*\ ; Linehan,\ W.M.*\ ; Adams,\ K.*\ ; Timmers,\ H.J.*\ ; Pacak,\ K.*
"); document.write("
Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status.
"); document.write("
Eur. J. Cancer 48, 1739-1749 (2012)
"); document.write("
"); document.write("
"); document.write("
Frank,\ B.*\ ; Weck,\ M.N.*\ ; Müller,\ H.*\ ; Klopp,\ N.\ ; Illig,\ T.\ ; Raum,\ E.*\ ; Brenner,\ H.*
"); document.write("
Polymorphisms in \MUC1\, \MUC2\, \MUC5B\ and \MUC6\ genes are not associated with the risk of chronic atrophic gastritis.
"); document.write("
Eur. J. Cancer 48, 114-120 (2012)
"); document.write("
"); document.write("
"); document.write("
Mutze,\ K.*\ ; Langer,\ R.*\ ; Schumacher,\ F.*\ ; Becker,\ K.*\ ; Ott,\ K.*\ ; Novotny,\ A.*\ ; Hapfelmeier,\ A.*\ ; Höfler,\ H.\ ; Keller,\ G.*
"); document.write("
DNA methyltransferase 1 as a predictive biomarker and potential therapeutic target for chemotherapy in gastric cancer.
"); document.write("
Eur. J. Cancer 47, 1817-1825 (2011)
"); document.write("
"); document.write("
"); document.write("
Ebelt,\ K.\ ; Babaryka,\ G.*\ ; Frankenberger,\ B.\ ; Stief,\ C.G.*\ ; Eisenmenger,\ W.*\ ; Kirchner,\ T.*\ ; Schendel,\ D.J.\ ; Nößner,\ E.
"); document.write("
Prostate cancer lesions are surrounded by FOXP3⁺, PD-1⁺ and B7-H1⁺ lymphocyte clusters.
"); document.write("
Eur. J. Cancer 45, 1664-1672 (2009)
"); document.write("
"); document.write("
"); document.write("
Issels,\ R.D.
"); document.write("
Hyperthermia adds to chemotherapy.
"); document.write("
Eur. J. Cancer 44, 2546-2554 (2008)
"); document.write("
"); document.write("
"); document.write("
Schaefer,\ K.L.*\ ; Eisenacher,\ M.*\ ; Braun,\ Y.*\ ; Brachwitz,\ K.*\ ; Wai,\ D.H.*\ ; Dirksen,\ U.*\ ; Lanvers-Kaminsky,\ C.*\ ; Juergens,\ H.*\ ; Herrero,\ D.*\ ; Stegmaier,\ S.*\ ; Koscielniak,\ E.*\ ; Eggert,\ A.*\ ; Nathrath,\ M.\ ; Gosheger,\ G.*\ ; Schneider,\ D.T.*\ ; Bury,\ C.*\ ; Diallo-Danebrock,\ R.*\ ; Ottaviano,\ L.*\ ; Gabbert,\ H.E.*\ ; Poremba,\ C.*
"); document.write("
Microarray analysis of Ewing\'s sarcoma family of tumours reveals characteristic gene expression signatures associated with metastasis and resistance to chemotherapy.
"); document.write("
Eur. J. Cancer 44, 699-709 (2008)
"); document.write("
"); document.write("
"); document.write("
Verweij,\ J.*\ ; Casali,\ P.G.*\ ; Kotasek,\ D.*\ ; LeCesne,\ A.L.*\ ; Reichard,\ P.*\ ; Judson,\ I.R.*\ ; Issels,\ R.D.\ ; van Oosterom,\ A.T.*\ ; van Glabbeke,\ M.*\ ; Blay,\ J.-Y.*
"); document.write("
Imatinib does not induce cardiac left ventricular failure in gastrointestinal stromal tumours patients: Analyis of EORTC-ISG-AGITG study 62005.
"); document.write("
Eur. J. Cancer 43, 974-978 (2007)
"); document.write("
"); document.write("
"); document.write("
Debiec-Rychter,\ M.*\ ; Sciot,\ R.*\ ; Le Cesne,\ A.*\ ; Schlemmer,\ M.\ ; Hohenberger,\ P.*\ ; van Oosterom,\ A.T.*\ ; Blay,\ J.Y.*\ ; Leyvraz,\ S.*\ ; Stul,\ M.*\ ; Casali,\ P.G.*\ ; Zalcberg,\ J.*\ ; Verweij,\ J.*\ ; van Glabbeke,\ M.*\ ; Hagemeijer,\ A.*\ ; Judson,\ I.*\ ; EORTC Soft Tissue and Bone Sarcoma Group (*)\ ; Italian Sarcoma Group (*)
"); document.write("
KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours.
"); document.write("
Eur. J. Cancer 42, 1093-1103 (2006)
"); document.write("
"); document.write("
"); document.write("
Rashid,\ M.U.*\ ; Wichmann,\ H.-E.
"); document.write("
German populations with infrequent CHEK2*1100delC and minor associations with early-onset and familial breast cancer.
"); document.write("
Eur. J. Cancer 41, 2896-2903 (2005)
"); document.write("
"); document.write("
"); document.write("
Zalcberg,\ J.R.*\ ; Verweij,\ J.*\ ; Casali,\ P.G.*\ ; Le Cesne,\ A.*\ ; Reichardt,\ P.*\ ; Blay,\ J.-Y.*\ ; Schlemmer,\ M.\ ; van Glabbeke,\ M.*\ ; Brown,\ M.*\ ; Judson,\ I.R.*
"); document.write("
Outcome of patients with advanced gastro-intestinal stromal tumours crossing over to a daily imatinib dose 800 mg after progression on 400 mg.
"); document.write("
Eur. J. Cancer 41, 1751-1757 (2005)
"); document.write("
"); document.write("
"); document.write("
Ensoli,\ B.*\ ; Sgadari,\ C.*\ ; Barillari,\ G.*\ ; Sirianni,\ M.C.*\ ; Stürzl,\ M.\ ; Monini,\ P.*
"); document.write("
Biology of Kaposi\'s sarcoma.
"); document.write("
Eur. J. Cancer 37, 1251-1269 (2001)
"); document.write("
"); document.write("
"); document.write("
Issels,\ R.D.\ ; Abdel-Rahman,\ S.*\ ; Wendtner,\ C.-M.\ ; Falk,\ M.H.*\ ; Kurze,\ V.*\ ; Sauer,\ H.*\ ; Aydemir,\ U.*\ ; Hiddemann,\ W.*
"); document.write("
Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults : Long-term results of a phase II study.
"); document.write("
Eur. J. Cancer 37, 1599-1608 (2001)
"); document.write("
"); document.write("
"); document.write("
Wendtner,\ C.-M.\ ; Abdel-Rahman,\ S.*\ ; Baumert,\ J.J.*\ ; Falk,\ M.H.*\ ; Krych,\ M.*\ ; Santl,\ M.*\ ; Hiddemann,\ W.*\ ; Issels,\ R.D.
"); document.write("
Treatment of primary, recurrent or inadequately resected high-risk soft-tissue sarcomas (STS) of adults : Results of a phase II pilot study (RHT-95) of neoadjuvant chemotherapy combined with regional hyperthermia.
"); document.write("
Eur. J. Cancer 37, 1609-1616 (2001)
"); document.write("
"); document.write("
"); document.write("
Wollenberg,\ B.\ ; Andratschke,\ M.*\ ; Pauli,\ C.*\ ; Ledderose,\ H.*\ ; Lindhofet,\ H.*\ ; Zeidler,\ R.
"); document.write("
Pilotstudy with a trifunctional bispecific antibody in patients with Head and Neck Cancer.
"); document.write("
Eur. J. Cancer 1, S61 (2001)
"); document.write("
"); document.write("
"); document.write("
Willeke,\ F.*\ ; Mechtersheimer,\ G.*\ ; Schwarzbach,\ M.*\ ; Weitz,\ J.*\ ; Zimmer,\ D.*\ ; Lehnert,\ T.*\ ; Herfarth,\ C.*\ ; von Knebel Doeberitz,\ M.*\ ; Ridder,\ R.*
"); document.write("
Detection of SYT-SSX1/2 fusion transcripts by reverse transcriptase-polymerase chain reaction (RT-PCR) is a valuable diagnostic tool in synovial sarcoma.
"); document.write("
Eur. J. Cancer 34, 2087-2093 (1998)
"); document.write("
"); document.write("
"); document.write("
Lau,\ B.\ ; Janka,\ G.E.*\ ; Meister,\ P.*\ ; Lampert,\ F.H.*\ ; Haas,\ R.J.*
"); document.write("
Childhood malignant lymphoma. Favourable outlook with aggressive combination chemotherapy and radiotherapy.
"); document.write("
Eur. J. Cancer 13, 1237-1240 (1977)
"); document.write("
");